CARDIOVATION: DRAGONS' DEN

Saturday, October 28, 2023

16:30 – 17:30 EST

Location: Palais, 517D

Host(s)

Chi-Ming Chow, MDCM MSc FRCPC FCCS

Professor in Medicine
St. Michael's Hospital, University of Toronto
University of Toronto

Dragon(s)

Jasmine Grewal, MD, FRCPC

Clinical Professor, University of British Columbia
St. Paul's Hospital
University of British Columbia
Hassan Mir, MD, FRCPC

Cardiologist and Assistant Professor
University of Ottawa Heart Institute
University of Ottawa Heart Institute
Seema Nagpal, PhD

Chief Science Officer
Canadian Cardiovascular Society
Subodh Verma, MD, PhD (he/him/his)

Cardiac Surgeon
CSCS
University of Toronto

Panelist(s)

Atul Verma, MD

Director of Cardiology
McGill University Health Centre
McGill University Health Centre
Saurabh Gupta, MD, MSc

Resident
McMaster University

Planning Committee Member(s)

Najah Adreak

MD,MSc, Clinical Researcher
The University of British Columbia/ BC Children Hospital
The University of British Columbia
Tara D'Ignazio

PGY-6 Cardiology
Université de Montréal
Université de Montréal
Varinder Randhawa, MD, PhD

Critical Care Fellow, AHFTx Cardiology
CANCARE, CHFS, CCTN, CSE
CCF and UofT

Disclosure(s):

Chi-Ming Chow, MDCM MSc FRCPC FCCS: USquareSoft Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Sonia Anand, MD, PhD, FRCPc, FRSC: Bayer AG: Speaker/Honoraria (Ongoing); Daiichi Sankyo: Speaker/Honoraria (Ongoing); Janssen Inc.: Speaker/Honoraria (Ongoing); Servier: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing)

Jasmine Grewal, MD, FRCPC: No financial relationships to disclose

Subodh Verma, MD, PhD: Amarin: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Amgen: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); AstraZeneca: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Bayer: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Boehringer-Ingelheim: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Canadian Medical and Surgical Knowledge Translation Research Group: Speaker/Honoraria (Ongoing); Eli Lilly: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); HLS Therapeutics: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Janssen: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Novartis: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordisk: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Pfizer: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); PhaseBio: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, February 17, 2023), Speaker/Honoraria (Terminated, February 17, 2023); S&L Solutions: Speaker/Honoraria (Ongoing); Sanofi: Speaker/Honoraria (Ongoing)

Come see an MIT and and EC member present and compete for recognition on an invention or innovation they have championed that can improve practice.

Submission included an innovation for an operations process improvement, new technology or repurposed technology to be considered as a presenter at the CCS Cardiovation Competition. The two selected submissions, by Dr. Saif Dababneh and Dr. Christopher Cheung, will face a panel of “Dragons,” including host Chi-Ming Chow, Sonia Anand, Jasmine Grewal, Subodh Verma, and the winner of the 2019 Cardiovation: Hassan Mir.

Presentations:

16:35 – 16:55 EST

DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
Innovator: Saif Dababneh, B.Sc – University of British Columbia
Innovator: Glen F. Tibbits, PhD – Cellular and Regenerative Medicine Centre
Innovator: Alia Arslanova, BSc – Cellular and Regenerative Medicine Centre
Submitter: Saif Dababneh, B.Sc – University of British Columbia
16:55 – 17:15 EST

SEEING THE BIG PICTURE: USING ARTIFICIAL INTELLIGENCE TO RECONSTRUCT THE 12-LEAD ECG
Innovator: Christopher C. Cheung, MD MPH FRCPC (he/him/his) – University of Toronto
Innovator: Yan Zhu
Innovator: Rahul Krishnan, PhD – University of Toronto
Submitter: Christopher C. Cheung, MD MPH FRCPC (he/him/his) – University of Toronto